Login

Switch On Your HIV Smarts.

Integrase Inhibitors Work Well to Treat NNRTI Drug Resistant HIV

Integrase Inhibitors Work Well to Treat NNRTI Drug Resistant HIV

, by Emily Newman

How do different HIV therapy regimens compare when people have transmitted drug resistance? A new study offers insight. Read More

FDA Approves Epclusa Combo Pill for All Types of Hepatitis C

FDA Approves Epclusa Combo Pill for All Types of Hepatitis C

, by Liz Highleyman

Epclusa is a new combo pill of sofosbuvir/velpatasvir that can cure hepatitis C in 12 weeks. Read More

Major Changes to AIDS Drug Assistance Program (ADAP) On July 1, 2016

Major Changes to AIDS Drug Assistance Program (ADAP) On July 1, 2016

, by San Francisco AIDS Foundation

Find out about possible out-of-pocket expenses and what you need to know to ensure there are no disruptions to your medication access. Read More

Identifying “hotspots” of HIV transmission with big data

Identifying “hotspots” of HIV transmission with big data

, by Emily Newman

Researchers in Canada are using big data to find HIV outbreaks, predict their course, and target people most at risk. Read More

FDA approves Descovy, an updated version of Truvada—but not for PrEP

FDA approves Descovy, an updated version of Truvada—but not for PrEP

, by Liz Highleyman

An updated tenofovir alafenamide combo pill is now available from Gilead Sciences, but it should not be substituted for Truvada as PrEP. Read More